Ad is loading...
MENU

ANIX Anixa Biosciences Forecast, Technical & Fundamental Analysis

a developer of non-invasive blood tests for the early detection of solid tumor based cancers

Industry Biotechnology
ANIX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ANIX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ANIX is expected to report earnings to fall 15.92% to -8 cents per share on January 01

Anixa Biosciences ANIX Stock Earnings Reports
Q4'24
Est.
$-0.09
Q3'24
Est.
$-0.10
Q2'24
Beat
by $0.01
Q1'24
Missed
by $0.01
Q4'23
Est.
$-0.09
The last earnings report on September 06 showed earnings per share of -10 cents, missing the estimate of -10 cents. With 6.72K shares outstanding, the current market capitalization sits at 97.99M.
A.I. Advisor
published General Information

General Information

a developer of non-invasive blood tests for the early detection of solid tumor based cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Computer Peripherals
Address
3150 Almaden Expressway
Phone
+1 408 708-9808
Employees
5
Web
https://www.anixa.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YGRAF0.710.02
+3.46%
Yangarra Resources Ltd.
GOFPY7.830.07
+0.90%
Greek Organisation of Football Prognostics SA
ANZGY21.080.11
+0.52%
ANZ GROUP HLDGS LTD
SGSOY9.78N/A
N/A
SGS SA
BLQC0.07-0.01
-8.26%
BlockQuarry Corp.

ANIX and Stocks

Correlation & Price change

A.I.dvisor tells us that ANIX and GERN have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANIX and GERN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
-2.40%
GERN - ANIX
28%
Poorly correlated
+5.28%
CDTX - ANIX
27%
Poorly correlated
-3.26%
SER - ANIX
25%
Poorly correlated
+5.20%
CLRB - ANIX
25%
Poorly correlated
-3.11%
RPTX - ANIX
25%
Poorly correlated
-1.39%
More